Vera Therapeutics, Inc. Class A Common Stock
Symbol: VERA (NASDAQ)
28.53
▼ (-1.84%) -0.535
Company Description:
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Key Stats
- Today's Open: $29.14
- Today's High: $29.375
- Today's Low: $28.155
- Today's Volume: 260.24K
- Yesterday Close: $29.06
- Yesterday High: $29.93
- Yesterday Low: $28.59
- Yesterday Volume: 1.67M
- Last Min Volume: 1.72K
- Last Min High: $28.615
- Last Min Low: $28.582
- Last Min VWAP: $28.60561
Company Profile
- Name: Vera Therapeutics, Inc. Class A Common Stock
- Website: https://www.veratx.com
- Listed Date: 2021-05-14
- Location: BRISBANE, CA
- Market Status: Active
- CIK Number: 0001831828
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.85B
- Round Lot: 100
- Outstanding Shares: 63.82M
- Asset Type: CS
RECENT FILINGS FOR VERA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-05 | 8-K | View |
| 2025-08-05 | 424B5 | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-06-25 | 4 | View |
| 2025-06-11 | SCHEDULE 13G | View |
| 2025-06-03 | 8-K | View |
| 2025-06-02 | 8-K | View |
| 2025-05-19 | 8-K | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-16 | 4 | View |
| 2025-05-07 | 10-Q | View |
| 2025-05-06 | 8-K | View |
Latest News on VERA